Publikationen Dr. rer. nat. Saskia Fuhrmann

Eine aktuelle Übersicht der Publikationen finden Sie unter folgenden Link (ORCID iD)

2021

Datzmann, T., Schmitt, J., Fuhrmann, S., Roessler, M., Meier, F., Schoffer, O. (2021)
Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data.
Cancers, 2021. 13(24): 6150.

2020

Fuhrmann, S., Tesch, F., Romanos, M., Abraham, S., Schmitt, J. (2020)
ADHD in school-age children is related to infant exposure to systemic H1-antihistamines.
Allergy, 2020. 75(11): 2956-2957.

2019

Fuhrmann, S., Koppen, A., Seeling, A., Knoth, H., Schröder, J. (2019)
Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin.
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 146: 21-27

2018

Dissertation: Physiologically-based pharmacokinetic and mechanism-based pharmacodynamic modelling of monoclonal antibodies with a focus on tumour targeting. Universität Potsdam, 2018.

(Published online at the Institutional Repository of the University of Potsdam: http://nbn-resolving.de/urn:nbn:de:kobv:517-opus4-418861)

2017

Fuhrmann, S., Kloft, C., Huisinga, W. (2017).
Impact of altered endogenous IgG on unspecific mAb clearance.
J Pharmacokinet Pharmacodyn 44(4):351-374.

2015

W. Huisinga, S. Fuhrmann, L. Fronton, B.-F. Krippendorff, “Target-Driven Pharmacokinetics of Biotherapeutics”, in: ADME Transl. Pharmacokinet. Ther. Proteins. Appl. Drug Discov. Dev., Eds.: H. Zhou and F.-P. Theil, Wiley, 2015, pp. 197-209.